Late-life depression (LLD) is associated with disability, increased risk for cognitive decline and dementia, elevated suicide risk, and greater all-cause mortality. These outcomes are related to depression being a recurrent disorder, with repeated episodes over a patient's lifetime. Recurrence rates (defined as including both relapse and recurrence) are high in LLD. The goals of this study are to identify neurobiological factors that predict recurrence risk, and examine how cognitive performance changes are both influenced by these neurobiological factors and also predict recurrence risk.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Neurobiology of Recurrence (Stress Reactivity)
Timeframe: Change in stress reactivity at Month 8, Month 16, and Month 24
Neurobiology of Recurrence (Functional Network Connectivity)
Timeframe: Change in functional network connectivity at Month 8, Month 16, and Month 24